Reviews
☆
☆
☆
☆
☆
“It was great to hear Meg Heim speaking about Medical Affairs planning and reframing cost as investment - love it”
Bilmoore via Apple Podcasts ·
United States of America ·
07/05/22
☆
☆
☆
☆
☆
“Really great insights here, very easy to listen to as well! thumbs up from me”
Demented pidgin via Apple Podcasts ·
Great Britain ·
06/30/22
☆
☆
☆
☆
☆
“Pharma launches are critical to the success and growth of companies large mid and small. They are very often make or break, and data show that more than 50% of launches fail to meet projections. This series offers global leaders speaking with Evermed CEO Dr Bozi Jovicevic, a 17-yr veteran of...”Read full review »
MDW-NYC via Apple Podcasts ·
United States of America ·
06/22/22
☆
☆
☆
☆
☆
“Pharma launch secrets is something that was missing in the market. It’s hard to find resources on this topic beyond classical IQVIA or McKinsey reports. Great idea.”
michaelreader via Apple Podcasts ·
United States of America ·
06/22/22
☆
☆
☆
☆
☆
“Real talk on how to launch pharma products… subscribed!”
High ffi via Apple Podcasts ·
Great Britain ·
06/21/22
☆
☆
☆
☆
☆
“I didn't know if I was going to get real insights into how pharma companies launch products because I always assumed they were really closed off and careful about what they told the public, but the host (Bosidar?) asks the right questions and gets the guests to give clear answers.”Read full review »
LMWales via Apple Podcasts ·
Great Britain ·
06/21/22
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
Listen now
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
